The Medicare GLP-1 Bridge is a temporary nationwide program that lets eligible people with Medicare prescription drug coverage buy certain GLP-1 weight-loss medications for a flat $50 monthly copay, no matter what their income level is
The same class of medication Semaglutide and dulaglutide are glucagon-like peptide-1 (GLP-1) receptor agonists
This means you might not be getting the full antioxidant benefit you paid for
While results vary, most patients will lose an average of 15% of their current body weight after 1 year
Pricing under their Zepbound Self Pay Journey Program (as of Feb 2025 updates) was approximately **$349/month for the 2.5mg** starting dose vial supply, and **$499/month for the 5mg, 7.5mg, and 10mg** vial supplies (the 7.5mg & 10mg required enrollment and timely refills to maintain the $499 price, otherwise reverting to higher prices)
The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the action to control cardiovascular risk in diabetes (ACCORD) eye study